Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility of a Mobile Application to Support Reflection and Dialog About Strengths in People With Chronic Illness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03437863
Recruitment Status : Completed
First Posted : February 19, 2018
Last Update Posted : March 15, 2019
Sponsor:
Collaborators:
South-Eastern Norway Regional Health Authority
Diakonhjemmet Hospital
Information provided by (Responsible Party):
Ólöf Birna Kristjánsdóttir, Oslo University Hospital

Brief Summary:
Self-management of chronic illness can be highly demanding and people need to mobilize their personal strengths in order to live well with their condition. A mobile application was designed in collaboration with people with chronic illness and health care providers with the aims to support awareness of patients' strengths and patient-provider dialogues that include strengths. The aim of the present study is to evaluate with mixed methods the perceived usefulness and usability of the application and potential effects of the application on patients.

Condition or disease Intervention/treatment Phase
Chronic Disease Rheumatic Diseases Device: Mobile application Not Applicable

Detailed Description:
In this pre-post design pilot study participants will be recruited from self-management courses for people with rheumatic diseases. Before using the application participants will be asked to report their strengths in a written format. After using the mobile application to reflect on their strengths the participants will be interviewed about their experience of using the application and on the task of reflecting on their strengths. They will also be asked to fill out a questionnaire on perceived usefulness and user-friendliness. Before and after using the application the participants fill out questionnaires on emotions (Positive and Negative Affective Scale) and self-efficacy (The Arthritis Self-efficacy Scale). All interviews will be audio-taped and analyzed with a qualitative approach. Descriptive analysis will be applied for quantitative data.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Intervention Model: Single Group Assignment
Intervention Model Description: Participants will be recruited to a pre-post design study.
Masking: None (Open Label)
Primary Purpose: Device Feasibility
Official Title: Capitalizing on the Strengths of Persons With Rheumatoid Arthritis to Improve Health and Wellness
Actual Study Start Date : April 18, 2018
Actual Primary Completion Date : September 20, 2018
Actual Study Completion Date : September 20, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Mobile application
Participants recruited from a self-management course are asked to use (single time) a mobile application to support reflection of personal strengths. The participant borrows an Ipad and uses the application to 1) reflect and identify their strengths by reviewing a list of examples, 2) define personal goals, and 3) link strengths to goals.
Device: Mobile application
Use of a mobile application (on a borrowed device) with following features: 1) strengths reflection and identification, 2) summary of registered strengths, 3) defining goals, and 4) linking strengths to goals.




Primary Outcome Measures :
  1. Perceived usefulness of the application [ Time Frame: Within a week after using the application ]
    Study-specific questions on perceived usefulness of the application


Secondary Outcome Measures :
  1. The System Usability Scale [ Time Frame: Within a week after using the application ]
    This 10 item questionnaire measures usability. Each item has 5 response options with total score ranging from 0 to 100. Higher values represent a better outcome.

  2. The Positive and Negative Affect Schedule. [ Time Frame: Within a week after using the application ]
    This scale measures positive and negative affect with two subscales (positive affect and negative affect). Positive affect subscale scores can range from 10-50, with higher scores representing higher levels of positive affect. Negative affect subscale scores can range from 10-50, with lower scores representing lower levels of negative affect.

  3. The Arthritis Self-efficacy Scale [ Time Frame: Within a week after using the application ]
    This scale measures self-efficacy with two subscales with 5 response options. The "pain" subscale has 5 items and a score range from 0 to 20. The "other symptoms" subscale has 6 items and a score range from 0 to 24. Higher scores equal higher levels of self-efficacy.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 100 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Setting 1:

Inclusion Criteria:

  • Age of 18 years or older
  • Can read and speak Norwegian language
  • Diagnosed with a chronic condition
  • Participating or having recently participated in a learning and mastery or an outpatient rehabilitation program

No exclusion criteria


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03437863


Locations
Layout table for location information
Norway
Diakonhjemmet Hospital
Oslo, Norway, 0370
Sponsors and Collaborators
Oslo University Hospital
South-Eastern Norway Regional Health Authority
Diakonhjemmet Hospital
Investigators
Layout table for investigator information
Principal Investigator: Olöf B Kristjansdottir, PhD Oslo University Hospital, Center for Shared Decision Making and Collaborative Care Research

Layout table for additonal information
Responsible Party: Ólöf Birna Kristjánsdóttir, Principal Investigator, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT03437863     History of Changes
Other Study ID Numbers: 2015065
First Posted: February 19, 2018    Key Record Dates
Last Update Posted: March 15, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Ólöf Birna Kristjánsdóttir, Oslo University Hospital:
self-management
health assets
Strengths
mHealth
Feasibility
Additional relevant MeSH terms:
Layout table for MeSH terms
Rheumatic Diseases
Collagen Diseases
Chronic Disease
Disease Attributes
Pathologic Processes
Musculoskeletal Diseases
Connective Tissue Diseases